Substance Abuse Treatment Centers
"Substance Abuse Treatment Centers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included.
|Drug Rehabilitation Center
- Drug Rehabilitation Center
- Center, Drug Rehabilitation
- Centers, Drug Rehabilitation
- Drug Rehabilitation Centers
- Treatment Centers, Drug Abuse
- Rehabilitation Center, Drug
- Rehabilitation Centers, Drug
- Treatment Centers, Drug
- Drug Abuse Treatment Centers
- Drug Treatment Centers
- Center, Drug Treatment
- Centers, Drug Treatment
- Drug Treatment Center
- Treatment Center, Drug
Below are MeSH descriptors whose meaning is more general than "Substance Abuse Treatment Centers".
Below are MeSH descriptors whose meaning is more specific than "Substance Abuse Treatment Centers".
This graph shows the total number of publications written about "Substance Abuse Treatment Centers" by people in this website by year, and whether "Substance Abuse Treatment Centers" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Substance Abuse Treatment Centers" by people in Profiles.
Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020 02 05; 3(2):e1920622.
Geissler KH, Evans EA. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity. Med Care. 2020 02; 58(2):101-107.
Andrews CM, Pollack HA, Abraham AJ, Grogan CM, Bersamira CS, D'Aunno T, Friedmann PD. Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat. 2019 07; 102:1-7.
Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Martin SA, Bosse J, Wilson A, Losikoff P, Chiodo L. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care. Addict Sci Clin Pract. 2018 04 25; 13(1):10.
Romo E, Ulbricht CM, Clark RE, Lapane KL. Correlates of specialty substance use treatment among adults with opioid use disorders. Addict Behav. 2018 11; 86:96-103.
Andrews CM, Grogan CM, Westlake MA, Abraham AJ, Pollack HA, D'Aunno TA, Friedmann PD. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018 04; 87:50-55.
Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29.
D'Aunno T, Pollack H, Chen Q, Friedmann PD. Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey. Med Care. 2017 04; 55(4):379-383.
Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction. 2017 May; 112(5):838-851.